Efficacy and Safety of Colesevelam HCl (COL) as an Add-On to Pioglitazone (PIO) for Type 2 Diabetes Mellitus (T2DM)

被引：0
|
作者：
Ford, Daniel M.
Baz-Hecht, Merav
Said, Nabil A.
Tao, Ben
Truitt, Kenneth E.
Chou, Hubert S.
机构：
来源：
DIABETES | 2013年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1060-P
引用
收藏
页码：A273 / A273
页数：1
相关论文
共 50 条
  • [31] Pioglitazone (PIO) improves atherogenic dyslipidemia in drug-therapy naive patients with type 2 diabetes (T2DM)
    Tan, MH
    Herz, M
    Johns, D
    Robertson, KE
    Gonzalez, B
    Reviriego, J
    Grossman, LD
    [J]. DIABETES, 2002, 51 : A497 - A497
  • [32] Add-on to metformin in T2DM—linagliptin or glimepiride?
    Mikkel Christensen
    Filip K. Knop
    [J]. Nature Reviews Endocrinology, 2012, 8 : 576 - 578
  • [33] Efficacy and Safety of Vildagliptin as Add-on to Metformin in Japanese Patients with Type 2 Diabetes Mellitus
    Masato Odawara
    Izumi Hamada
    Manabu Suzuki
    [J]. Diabetes Therapy, 2014, 5 : 169 - 181
  • [34] Efficacy and Safety of Vildagliptin as Add-on to Metformin in Japanese Patients with Type 2 Diabetes Mellitus
    Odawara, Masato
    Hamada, Izumi
    Suzuki, Manabu
    [J]. DIABETES THERAPY, 2014, 5 (01) : 169 - 181
  • [35] Patient Characteristics Associated with Add-On Medication Treatment for Patients with Type 2 Diabetes Mellitus (T2DM) Who Failed Metformin Monotherapy
    Qiu, Ying
    Fu, Alex Z.
    Radican, Larry
    [J]. DIABETES, 2010, 59 : A604 - A604
  • [36] Microvascular complications in type 2 diabetes mellitus (T2DM).
    Cheung, AT
    Ramanujam, S
    Duong, PL
    Schauer, D
    Chan, LS
    Dwyre, DM
    Larkin, EC
    [J]. FASEB JOURNAL, 2002, 16 (04): : A208 - A208
  • [37] The platelets characteristics in type 2 diabetes mellitus (T2DM)
    Buryachkovskaya, L.
    Uchitel, I. A.
    Sumarokov, A. B.
    Docenko, U., V
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 931 - 931
  • [38] Vascular responsiveness in type 2 diabetes mellitus (T2DM)
    Blum, A.
    Socea, D.
    Sirchan, R.
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2016, 109 (12) : 791 - 796
  • [39] Pharmacogenomics and pharmacomicrobiomics in type 2 diabetes mellitus (T2DM)
    Luo, Jian-Quan
    Shu, Yan
    Zhang, Wei
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [40] Progression of microalbuminuria during a long-term open-label (OL) trial of pioglitazone (PIO) in patients with type 2 diabetes mellitus (T2DM)
    Perez, A
    Cichy, S
    Glazer, B
    [J]. DIABETES, 2002, 51 : A111 - A111
12345